Pharmaceutical

Lilly and EVA Pharma to expand baricitinib access in Africa

Eli Lilly and EVA Pharma have formed a partnership to increase the availability of baricitinib in 49 African countries by 2030.

Sep 6, 2024 - 04:00
Lilly and EVA Pharma to expand baricitinib access in Africa
Eli Lilly and EVA Pharma have formed a partnership to increase the availability of baricitinib in 49 African countries by 2030.
Read the original article

Tags:

Previous Article

ArsenalBio secures $325m to develop cell therapy programmes

Next Article

Phase 2/3 of Athira Trial for Alzheimer’s Fails

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Novo Nordisk acquires Alkermes’s Irish plant to expand manufacturing capacity

Novo Nordisk acquires Alkermes’s Irish plant to expand ...

Dec 14, 2023

Purdue receives clearance for opioid overdose injector for younger individuals

Purdue receives clearance for opioid overdose injector ...

Aug 9, 2024

NICE recommends Boehringer’s tenecteplase for NHS stroke care

NICE recommends Boehringer’s tenecteplase for NHS strok...

Jul 26, 2024